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Abstract
Craniofacial and cardiac development relies on the proper patterning of the neural crest-derived ectomesenchyme of the pharyngeal
arches, from which many craniofacial and great vessel structures arise. One of the intercellular signaling molecules that is involved in this
process, endothelin-1 (ET-1), is expressed in the arch epithelium and influences arch development by binding to its cognate receptor, the
endothelin A (ETA) receptor, found on ectomesenchymal cells. We have previously shown that absence of ETA signaling in ETA/ mouse
embryos disrupts neural crest cell development, resulting in craniofacial and cardiovascular defects similar in many aspects to those in
mouse models of DiGeorge syndrome. These changes may reflect a cell-autonomous requirement for ETA signaling during crest cell
development because the ETA receptor is an intracellular signaling molecule. However, it is also possible that some of the observed defects
in ETA/ embryos could arise from the absence of downstream signaling that act in a non-cell-autonomous manner. To address this
question, we performed chimera analysis using ETA/ embryonic stem cells. We observe that, in almost all early ETA/7 / chimeric
embryos, ETA/ cells are excluded from the caudoventral aspects of the pharyngeal arches, suggesting a cell-autonomous role for ETA
signaling in crest cell migration and/or colonization. Interestingly, in the few embryos in which mutant cells do reach the ventral arch,
structures derived from this area are either composed solely of wild type cells or are missing, suggesting a second cell-autonomous role for
ETA signaling in postmigratory crest cell differentiation. In the cardiac outflow tract and great vessels, ETA/ cells are excluded from the
walls of the developing pharyngeal arch arteries, indicating that ETA signaling also acts cell-autonomously during cardiac neural crest cell
development.
© 2003 Elsevier Inc. All rights reserved.
Keywords: Neural crest cell; Pharyngeal arch; Chimera; Mouse; Craniofacial; Cardiovascular
Introduction
The development of most of the bone and cartilage of the
jaw and throat, as well as the cardiac outflow tract and aortic
arch, relies on neural crest cells (Kirby et al., 1983, 1985; Le
Lievre and Le Douarin, 1975; Noden, 1983). These cells
originate from the posterior midbrain and hindbrain, mi-
grate to the pharyngeal arches (Lumsden et al., 1991; Ser-
bedzija et al., 1992) and arch arteries (Kirby et al., 1983;
Kirby and Stewart, 1983), and subsequently contribute to
the formation of mature structures of the head and heart
(Creazzo et al., 1998; Kontges and Lumsden, 1996; Le
Douarin et al., 1993). The development of neural crest cells
is regulated by a number of factors expressed by the over-
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lying arch epithelium and arch artery endothelium. Endo-
thelin-1 (ET-1) is expressed by ectodermal and endodermal
arch epithelium, as well as by the paraxial mesoderm-
derived arch core, and has been hypothesized to be a crucial
factor in establishing rostral–caudal arch polarity of the first
mandibular arch (Tucker et al., 1999).
Inactivation of genes encoding ET-1 (Kurihara et al.,
1994), the endothelin-A (ETA) receptor (Clouthier et al.,
1998) (the primary receptor for ET-1 on cephalic crest
cells), and endothelin converting enzyme (ECE-1) (the es-
sential protease for the biosynthesis of ET-1; Yanagisawa et
al., 1998a) all result in specific defects in craniofacial and
cardiovascular structures derived from cephalic and cardiac
neural crest cells. Many of these defects overlap with those
found in patients with DiGeorge (velo-cardiofacial) syn-
drome and its recently described mouse models (Jerome and
Papaioannou, 2001; Lindsay et al., 2001; Merscher et al.,
2001; Kochilas et al., 2002; Vitelli et al., 2002). Craniofa-
cial defects associated with loss of endothelin signaling are
most pronounced in ventral arch derivatives and reflect the
arch area in which ETA signaling is crucial for initiating or
maintaining expression of multiple transcription factors
(Clouthier et al., 2000). However, craniofacial defects in
ETA/ embryos are not confined to the derivatives of the
ventral half, suggesting either that ETA signaling can influ-
ence lateral arch patterning through other paracrine media-
tors or that these defects occur as a secondary event to the
ventral defects.
ETA receptor signaling also plays a critical role in car-
diac neural crest cell development (Clouthier et al., 1998;
Kurihara et al., 1994; Yanagisawa et al., 1998a,b). We
previously showed that ETA receptor signaling by the crest-
derived mesenchymal cells that normally surround the arch
arteries is crucial for correct remodeling of arch arteries 4
and 6 (Clouthier et al., 1998; Yanagisawa et al., 1998b).
However, defects in remodeling of arch artery 3 were not
observed, suggesting that ETA receptor signaling is neces-
sary only for the development of arch arteries 4 and 6 or that
in arch arteries 3, it can be compensated for by other factors.
It is also possible that ETA action is required by all arch
arteries, but structural defects can only be detected in arter-
ies 4 and 6.
Fig. 3. Contribution of ETA/ or ETA/ cells to craniofacial structure of
E13.5 chimeric embryos. Structures examined are listed along the top, as
well as their arch of origin. The genotype of the embryos is listed along the
left. Because the phenotype of the ETA/7/ chimeras was the same
in each chimera examined, all six were combined. For ETA/7/
chimeras, the relative chimerism is listed in parenthesis next to the embryo
number: , 1–33% contribution of injected cells; , 34–66% contribu-
tion of injected cells; , 67–100% contribution of injected cells. ,
structures composed of both injected and recipient cells; , structures
composed of recipient cells only; , structures that are absent. While all
structures in ETA/7/ chimeras are composed of both ETA/ and
recipient wild type cells, ventral structures (Meckel’s cartilage, malleus
and lessor horns of the hyoid) in ETA/7/ chimeras are composed of
wild type cells only. In ETA/7/ chimeras containing a high per-
centage of ETA/ cells, these ventral structures are absent. More lateral
structures (incus, stapes and styloid) are composed of both ETA/ and
recipient wild type cells; like the ventral structures, these elements are
absent in chimeras containing a high percentage of mutant cells.
Fig. 1. Contribution of ETA wild type and mutant cells to the developing pharyngeal arches of chimeric embryos. Whole-mount -galactosidase staining of
ETA/7/ (A–C) and ETA/7/ mutant (D–F) chimeras are shown at E8.5 (A, D), E9.5 (B, E), and E11.5 (C, F). Upper insets show a magnification
of the pharyngeal arch region; the lower insets show transverse sections through the left mandibular arch of the embryos; sections are counterstained with
eosin. To aid in visualization, lower insets in (C) and (F) are shot in dark field, resulting in -gal staining appearing pink. For orientation purposes, lateral
(l), ventral (v), rostral (r), and caudal (c) aspects of the mandibular arch are denoted. At E8.5, no obvious differences are observed in cell distribution between
ETA/7/ (A) and ETA/ 7/ chimeric (D) embryos. However, at both E9.5 and E11.5, ETA/ cells (blue) are excluded from the caudoventral
aspects of the arches of ETA/7/ chimeras (yellow arrows), with ventral aspects composed almost solely of wild type (unstained) cells (E, F). In a few
ETA/7/ chimeras, scattered clumps of ETA/ cells are observed in more ventral regions (white arrow in lower inset in F). In contrast, ETA/ cells
(blue) are found throughout the arches of ETA/7/ chimeras and are mixed homogeneously with wild type (unstained) cells (B, C). The distribution
of ETA/ cells was unchanged in other regions of ETA/7/ chimeras.
Fig. 2. Development of craniofacial structures in E13.5 chimeric embryos. Transverse sections from ETA/7/ (A, C) and ETA/7/ (B, D)
chimeras stained for -galactosidase activity (blue) and counterstained with eosin (pink). (A, B) Sections through the middle ear region. In ETA/7/
chimeras, ETA/ cells (blue) are observed in the malleus (m) and Meckel’s cartilage (mc) (and the surrounding mesenchyme), as well as the stapes (s), and
are mixed homogeneously with wild type (pink) cells (A). In contrast, ETA/ cells (blue) in ETA/7/ chimeras are only observed in the stapes (B).
The malleus and Meckel’s cartilage are composed only of wild type cells (pink). (C, D) Sections through the distal aspects of Meckel’s cartilage. While
ETA/ cells in ETA/7/ chimeras are observed in and surrounding Meckel’s cartilage (C), ETA/ cells in ETA/7/ chimeras are absent from
both Meckel’s cartilage and the surrounding perichondrium (D).
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The use of chimeras, in which mutant cells are mixed
with wild type cells and their involvement in development
subsequently followed, can help define whether a gene acts
in a cell-autonomous or non-cell-autonomous manner (Ros-
sant and Spence, 1998). Several chimera analyses have been
performed to examine the role of different genes in pharyn-
geal arch and cardiac development (Chen and Behringer,
1995; Rivera-Perez et al., 1999; Tran and Sucov, 1998). To
better understand the role of ETA signaling in the develop-
ment of individual craniofacial elements and the cardiac
outflow tract, we have undertaken chimera analysis using
ETA/ ES cells. We find that ETA/ cells are almost
always excluded from the caudoventral pharyngeal arches
of ETA/ 7 / chimeras during arch development in a
pattern consistent with a cell-autonomous requirement for
ETA signaling during neural crest cell migration. Examina-
tion of older embryos illustrates that most elements derived
from the ventral aspects of mandibular arch one and arch
two, including the mandible and Meckel’s cartilage, are
either composed solely of wild type cells or are absent,
regardless of whether any mutant cells reach the ventral
arch. In contrast, elements derived from the lateral aspects
of both the maxillary part of arch one and arch two, includ-
ing the incus and stapes, are composed of both wild type and
mutant cells. These findings suggest a second cell-autono-
mous requirement for ETA signaling during neural crest cell
differentiation in the ventral arch. In the cardiac outflow
tract, ETA/ cells are excluded from the walls of arch
arteries 3, 4, and 6, suggesting that ETA signaling is also
required in a cell-autonomous manner by cardiac neural
crest cells during their development.
Materials and methods
Generation and maintenance of ETA/ mice
The targeted disruption of the ETA allele was previously
described (Clouthier et al., 1998). Briefly, exons 5 and 6,
encoding the sixth and seventh transmembrane spanning
domains of the ETA receptor, were replaced with a targeting
vector through homologous recombination. ETA/ mice
were maintained on a 129S6/SvEv background and geno-
typed by PCR (Clouthier et al., 1998). For generation of ES
cells, ETA/ mice were bred with ROSA26 hemizygous
mice obtained from The Jackson Laboratories. These mice
carry an insertion vector containing a lacZ gene, which is
ubiquitously expressed in all embryonic tissues throughout
development (Friedrich and Soriano, 1991). Mice were
genotyped for the ROSA26 insertion by using a three primer
PCR that delineates wild type, hemizygous, and homozy-
gous ROSA26 mice. The mutant allele is amplified by using
primers F150 (5-GGCTTAAAGGCTAACCTGATGTG-3)
and R1295 (5-GCGAAGAGTTTGTCCTCAACC-3), which
amplifies an 1146-bp product. The wild type allele is amplified
with F150 and R523 (5-GGAGCGGGAGAAATG-
GATATG-3), which amplifies a 374-bp product.
Production of ETA/ ES cells
ES cell lines were generated from delayed blastocysts
obtained from matings between ETA/; ROSA26/ mice
by using previously described methods (Robertson, 1987).
Cell lines were genotyped for the ETA allele by both PCR
and Southern blot analyses, and for the ROSA26 allele by
PCR.
Generation and characterization of ETA chimeras
ETA/, /, or / ES cells (all of which also contained
the ROSA26 insertion vector) at passage 3–6 were injected
into blastocysts obtained from C57BL6/J female mice. Chi-
meric embryos examined at E8.5, E9.5, and E11.5 were
collected into phosphate-buffered saline (PBS, Life Tech-
nologies), fixed in 4% paraformaldehyde for 1 h at 4°C and
then stained for -galactosidase activity as previously de-
scribed (Zambrowicz et al., 1994). After staining, embryos
were rinsed in PBS, processed into paraffin, and sectioned
transversely at 5 m. Chimeric embryos examined at E13.5
and E18.5 were first embedded in OCT freezing media
(Tissue-Tek) and snap frozen. A Leica cryostat was then
used to cut 14-m sections, which were collected onto
poly-L-lysine slides (Histology Control Systems), air dried,
fixed in 0.5% gluteraldehyde for 20 min, rinsed, and then
stained for -galactosidase activity overnight at 37°C. After
rinsing in PBS, slides were lightly counterstained with eosin
before coverslipping with PBX mounting media (BDH Lab-
oratory Chemicals). For all of these analyses, X-gal (Phar-
macia) was used as the substrate for -galactosidase.
Analysis of -galactosidase staining
To grossly determine the overall contribution of injected
ES cells in E13.5 and E18.5 chimeric embryos, six consec-
utive sections in both the head and heart regions were
examined. In E18.5 embryos, this was further confirmed by
analyzing -galactosidase staining in trunk skin. To do this,
back trunk skin was removed prior to embryo embedding,
spread onto a small piece of 3MM Whatman paper, fixed in
0.5% gluteraldehyde for 20 min at 4°C, rinsed in PBS, and
stained for -galactosidase overnight at 37°C.
Bone and cartilage staining
E18.5 ETA/7 / and ETA/7 / embryos were
collected and processed for bone and cartilage staining by
using alizarin red and alcian blue, respectively, as previ-
ously described (Clouthier et al., 1998).
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Results
To examine the cell-autonomous nature of ETA receptor
signaling during craniofacial and cardiovascular develop-
ment, we created chimeric embryos containing a mixture of
wild type and ETA/ cells. To accomplish this, we first
bred ETA/ mice with mice from the ROSA26 line; these
mice carry a lacZ insertion vector that is ubiquitously ex-
pressed throughout development (Friedrich and Soriano,
1991). Crossing ROSA26 onto the ETA/ background al-
lowed us subsequently to follow both ETA/ and ETA/
cells in chimeric embryos by staining for -galactosidase
(-gal) activity. ES cells were isolated from delayed blas-
tocysts obtained from matings of ETA/;ROSA26/ mice,
with 68 plated blastocysts giving rise to 17 ES cell lines, 2 of
which were ETA/;ROSA26/ and 2 of which were
ETA/; ROSA26/ (data not shown). This method of ES cell
isolation provided low passage ES cell lines for injection, thus
reducing the chance of ES cell differentiation. Both ETA/;
ROSA26/ cell lines (clones 53 and 75) were injected into
wild type blastocysts, giving rise to ETA/ 7 / mutant
chimeric embryos. As similar patterns were observed in
ETA/ 7 / chimeras at E9.5 and E10.5 using either of
these clones, we focused the bulk of our analysis on clone 53.
One ETA/;ROSA26/ cell line (clone 42) was injected into
wild type blastocysts to produce ETA/ 7 / control chi-
meras. One ETA/;ROSA26/ cell line (clone 74) was also
injected as a control and gave the same results as the ETA/;
ROSA26/ cells (data not shown). A total of 737 blastocysts
were injected, 397 embryos of varying ages collected, of which
288 were chimeric. The extent of chimerism ranged from5%
to 95%, with a mean of 50% (data not shown).
Segregation of ETA mutant cells in the pharyngeal arches
We first examined the contribution of ETA/ cells in
early ETA/ 7 / chimeras using whole-mount -gal
staining. Since ETA/ embryos have numerous craniofa-
cial defects that apparently arise from aberrant neural crest
cell development, we focused our analysis on pharyngeal
arch development. We initially examined E8.5, E9.5, and
E11.5 embryos because this time period would encompass
both crest migration away from the neural tube and initial
differentiation once in the pharyngeal arches (Chai et al.,
2000; Lumsden et al., 1991; Serbedzija et al., 1992). Em-
bryos were collected, fixed, stained for -gal activity, and
serially sectioned.
At E8.5, no detectable differences were noted between
ETA/7 / and ETA/7 / chimeric embryos, with
ETA/ and ETA/ cells contributing equally to all tissues
(blue cells in Fig. 1A and D). This included the first arch,
where transverse sections confirmed this mixing (lower in-
sets, Fig. 1A and D). Differences were also not observed in
ETA/ 7 / chimeras at E9.5 (Fig. 1B) or E11.5 (Fig.
Fig. 4. Skeletal analysis of craniofacial structures in E18.5 chimeric embryos. Lateral (A–C) and ventral (D–F) views of the skulls of ETA/7/ chimeras
(A, D), ETA/ 7/ chimeras (B, E) and ETA/ embryos (C, F) stained with alizarin red and alcian blue. Numerous changes are observed in neural
crest-derived skull elements in ETA/7/ chimeras (B, E), representing an intermediate phenotype between ETA/7/ chimeras and ETA mutant
embryos. These changes include truncation of Meckel’s cartilage (mc; green arrow), reduction in mandible (ma) size and organization, abnormal lessor horns
of the hyoid (h), and asymmetrical reduction in tympanic ring (ty) size. Red arrows in (E) point to the struts that form between the gonial (g) and pterygoid
(pt) bones. bs, basisphenoid; m, malleus; oc, otic capsule.
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1C), in which ETA/ and wild type cells were mixed in a
homogenous pattern throughout the arches. However, in
E9.5 (Fig. 1E) and E11.5 (Fig. 1F) ETA/7 / chimeric
embryos, ETA/ cells were excluded from a caudoventral
wedge in the first and second arches, with this region instead
being composed almost solely of unstained wild type cells
(compare yellow arrows in Fig. 1B and C and E and F).
Mutant cells were observed in more rostrolateral regions of
the arch, and -gal staining in this region appeared darker
than in control chimeras. This was further apparent in trans-
verse sections through the first arch (compare lower insets
in Fig. 1B and C and E and F). This segregation was
observed in 35/37 ETA/ 7 / embryos examined at
E9.5 and 25/27 ETA/7 / embryos examined at E11.5.
Further, the degree of segregation was inversely related to
the extent of mutant cell contribution: as the contribution of
ETA/ cells in the chimera increased, this sharp ETA/
boundary extended further in a caudoventral direction (data
not shown). Two ETA/ 7 / chimeras, in which the
contribution of ETA/ cells was greater than 90%, had blue
cells at the ventral most aspects of the arches (data not
shown). From these findings, it appears that wild type cells
either have an advantage reaching the ventral arch or pro-
liferating once there.
Contribution of ETA/ cells to arch derived structures in
mutant chimeras
We next examined the contribution of ETA/ and ETA/
cells to developing craniofacial structures in E13.5 ETA/
7 / and ETA/ 7 / chimeras by examining -gal
activity in transverse frozen sections. In ETA/ 7 / chi-
meras, ETA/ cells (blue) were observed throughout struc-
tures derived from the maxillary arch (incus), mandibular arch
(Meckel’s cartilage and the malleus), and second arch (stapes)
(n  6) (Figs. 2A and 3). In contrast, ETA/ cells (blue) in
ETA/7 / chimeras were conspicuously absent from the
malleus and Meckel’s cartilage, as well as in the surrounding
head and jaw mesenchyme (n 11) (Figs. 2B and 3). This area
was instead composed of wild type cells (pink). Mutant cells
were also not observed in the lessor horns of the hyoid bone.
This lack of contribution was independent of the percentage of
mutant cells present. More importantly, in ETA/ 7 /
chimeras containing a large percentage of mutant cells, these
structures were absent (Fig. 3). However, ETA/ cells were
always mixed in a homogenous pattern with wild type cells in
the incus and stapes (Figs. 2B and 3). It thus appears that
ETA/ cells cannot contribute to structures derived from the
mandibular arch or ventral second arch, but can participate in
the formation of structures derived from the maxillary arch and
lateral second arch in the presence of wild type cells.
Structural analysis of skull elements
The inability of mutant cells to contribute to ventral arch
elements in E13.5 ETA/ 7 / chimeric embryos sug-
gested the possibility that the development of these ventral
elements could be adversely affected in ETA/ 7 /
chimeric embryos with a high percentage of mutant cells.
To investigate this point, we examined arch-derived bone
and cartilage structures of the head of E18.5 embryos using
alizarin red and alcian blue staining. As expected, we ob-
served defects in numerous structures of ETA/ 7 /
chimeras (n  12) (Figs. 4B and E, and 5). These defects
represented an intermediate phenotype between ETA/
7 / chimeras (n  5) (Fig. 4A and D) and ETA/
embryos (Fig. 4C and F). The changes in ETA/ 7 /
chimeras included maldevelopment of the mandible and
tympanic rings and truncation of Meckel’s cartilage in its
lateral aspects (green arrow in Fig. 4E). An abnormal strut-
like structure connected the gonial bone to the pterygoid
bone (red arrows in Fig. 4E; see below). Interestingly,
morphological changes were also observed in structures that
were composed of both wild type and ETA/ cells in E13.5
ETA/ 7 / chimeras, including the incus and stapes
(Fig. 5). Thus, as the percentage of mutant cells increased in
ETA/7 / chimeras, a general shift occurred in cranio-
facial morphology toward that observed in ETA/ em-
bryos.
An interesting change in skull development in ETA/
7 / chimeras was the formation of an abnormal bone
strut that formed a bridge between the gonial and pterygoid
bones, both of which were malformed (red arrows Fig. 4E).
This strut, never observed in ETA/ embryos (Fig. 4F),
appears similar to struts observed in Dlx2/ (Qiu et al.,
1995, 1997) and Dlx5/ (Acampora et al., 1999; Depew et
al., 1999) embryos, though each has its own unique char-
acteristics.
Contribution of ETA/ cells to arch-derived structures in
E18.5 chimeras
The above results show that, while malformations were
observed in most of the arch-derived craniofacial structures
of E18.5 ETA/ 7 / chimeras, ventral structures were
predominately affected. To determine whether this reflected
differences in cell composition of these structures as seen in
E13.5 embryos, we examined the contribution of ETA/
cells to craniofacial structures of E18.5 ETA/ 7 /
chimeras using serial frontal sections stained for -gal ac-
tivity. As observed at E13.5, ETA/ cells were mixed
homogeneously throughout craniofacial structures in
ETA/ 7 / chimeras (n  5) (Fig. 6A and C, and
Fig. 7). In contrast, most ventral first arch structures in
ETA/ 7 / chimeras, including Meckel’s cartilage and
the mandible, were either composed solely of wild type cells
or were absent (n  12) (Fig. 7). More lateral structures,
including the incus and stapes, were composed of both wild
type and ETA/ cells, though these structures were often
malformed in ETA/ 7 / chimeras containing a large
percentage of mutant cells. Thus, ETA signaling appears to
be required cell-autonomously only in ventral arch devel-
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opment. Interestingly, the strut observed on skeletal analysis
that connected the gonial bone to the pterygoid bone was
composed of both wild type and ETA/ cells (data not
shown).
Pharyngeal arch artery development in mutant chimeras
ETA/ embryos have cardiac outflow tract and septation
defects indicative of aberrant cardiac neural crest develop-
ment (Clouthier et al., 1998). We had previously observed
that, while expression of both ET-1 and the ETA receptor are
observed in arch arteries 3, 4, and 6 (Clouthier et al., 1998),
defects in ETA/ embryos are only observed in arch arter-
ies 4 and 6 (Yanagisawa et al., 1998b). To better understand
the basis for these differences, we analyzed the contribution
of ETA/ cells to the caudal arches and arch artery deriv-
atives in ETA/ 7 / chimeras. At E10.0, labeled
ETA/ cells (blue) in ETA/7 / chimeras were mixed
with wild type cells (pink) in the areas surrounding arch
arteries 3, which give rise to the adult right and left common
carotid arteries (Fig. 8A). However, in ETA/ 7 /
chimeras, ETA/ cells were excluded from most of arch 3
(Fig. 8B), though as described above, the extent of exclu-
sion decreased as the percentage of mutant cells increased
(data not shown). In E13.5 (n  6) and E18.5 (n  5)
ETA/ 7 / chimeras, ETA/ and wild type cells were
intermixed around all outflow tract structures, including the
ascending aorta (data not shown), common carotid arteries,
the aortic arch (derived from left arch artery 4), the junction
of the right common carotid with the right subclavian (de-
rived from right arch artery 4), and the ductus arteriosus
(derived from left arch artery 6) (Fig. 8C, E, and G, and Fig.
9). In contrast, only wild type cells in E13.5 (n  7) and
E18.5 (n  7) ETA/ 7 / chimeras were observed in
outflow tract and arch artery structures, including the aortic
arch and the wall of the ductus arteriosus (*) (Fig. 8D, F,
and H, and Fig. 9). ETA/ cells were still observed in other
structures not normally populated by cardiac neural crest
cells, including the descending aorta (data not shown). In
one chimera containing a large percentage of ETA/ cells,
a ventricular septal defect (VSD) and right-sided aortic arch
were observed, defects often observed in ETA/ embryos.
Fig. 5. Analysis of craniofacial structures in E18.5 ETA/7/ and ETA/7/ chimeras. As described in Fig. 3, the structures examined are listed
along the top of the figure, the genotype of the embryos is listed along the left and the relative contribution of injected cells is listed to the right of the embryo
number ( to ). This analysis is based on alizarin red and alcian blue staining. , structures which are present and have normal architecture; ,
structures which are present but malformed; , structures which are absent. For comparison, observations from E18.5 ETA/ embryos (Clouthier et al., 1998)
are shown along the bottom. All structures examined in ETA/7/ chimeras appear normal. In contrast both ventral structures (Meckel’s cartilage
through the malleus in the first arch and the lessor horns of the hyoid in the second arch) and lateral structures (incus, stapes and styloid) in ETA/7 /
chimeras become increasingly malformed as the contribution of injected mutant cells increases, eventually resembling ETA/ embryos.
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While these results suggest a cell-autonomous requirement
for ETA signaling by cardiac neural crest cells, the exact
mechanism by which loss of ETA signaling causes specific
arch artery defects (Yanagisawa et al., 1998b) remains to be
determined.
Discussion
Recent studies by us and others suggest that ET-1/ETA
signaling may provide patterning information in the ventral
pharyngeal arches. In this study, we have shown that the
development of caudoventral arch-derived elements re-
quires ETA signaling in a cell-autonomous manner. This
requirement does not apply for more lateral arch elements,
even though many are malformed or absent in ETA/
embryos. These findings illustrate the complexity of inter-
cellular signaling in regional patterning of the pharyngeal
arches during craniofacial development.
Segregation of wild type and ETA mutant cells during
arch development
The first observable difference in ETA/7 / chime-
ras as compared with control chimeras is the exclusion of
ETA/ cells from the caudoventral pharyngeal arches at
E9.5. ETA/ cells are instead observed in the rostrolateral
arch, with -gal staining in this area more intense than in
control chimeras. While this could be due to differences in
proliferation between wild type and mutant cells, gross
changes in the proliferation of ETA/ cells were not de-
tected in our preliminary experiments using BrdU incorpo-
ration (data not shown). A more likely explanation for this
segregation is that mutant cells have a migratory defect and
thus accumulate in more lateral areas. This possible require-
ment for ETA signaling in crest cell migration is in contrast
to previous inferences from ETA/ mouse embryos
(Clouthier et al., 2000) and suc/et-1 mutant zebrafish lack-
ing the ET-1 homolog sucker (Miller et al., 2000), in which
the expression of molecular markers of migratory cephalic
crest cells appeared normal. Further, injection of human
ET-1 into suc/et-1 mutants at a stage after most crest mi-
gration is supposedly complete resulted in normal develop-
ment of ventral arch derivatives (Miller et al., 2000). These
findings led the authors to speculate that suc/et-1 (and thus
ETA receptor signaling), is not necessary for overall crest
cell migration. However, our present findings are compati-
ble with a model in which cephalic crest cells require ETA
receptor signaling in a cell-autonomous manner for proper
migration. This requirement in not likely absolute, since
ETA/ cells can reach the ventral arch if the contribution of
wild type cells is less than 10%. Using rhombomeric trans-
plantation analysis, Baker et al. (1997) demonstrated that
the ability of crest cells to enter and populate an arch is
blocked if other crest cells are already present. Thus, if wild
type cells arrive in the ventral arch before ETA/ cells do,
mutant cells would be unable to enter the ventral arch and
thus accumulate in the lateral arch.
How could loss of ETA signaling affect crest migration?
Interaction of different cell adhesion molecules on the sur-
face of crest cells is known to affect neural crest cell
motility (Xu et al., 2001). It is possible that loss of ETA
signaling disrupts the expression of one or more of these
cell adhesion complexes, thus disrupting movement through
the arch. That ETA/ cells appear to have trouble migrating
into the ventral arch might suggest that different “compart-
ments” exist within the arch, each requiring different cell
adhesion complexes for traversing. ETA/ cells may be
able to traverse some regions better than others, possibly
explaining why the line delineating wild type and mutant
cells in the first and second arches is so sharp (Fig. 1D and
F). Determining how loss of ETA signaling disrupts neural
crest development will require further studies.
Cell-autonomous requirement for ETA signaling in neural
crest differentiation
While ETA signaling may play a role in neural crest cell
migration, our data also suggest that it may play a second
role in terminal differentiation of crest cells into bone and
cartilage structures within the ventral aspects of the first
mandibular arch and second arch. In ETA/ 7 / chi-
meras, skeletal structures specifically derived from the ven-
tral mandibular arch, including the mandible and Meckel’s
Fig. 6. Development of middle ear structures in E18.5 chimeric embryos. Frontal sections from ETA/7/ (A, C) and ETA/7/ (B, D) chimeric
embryos are shown. Sections are counterstained with eosin (pink). (A, B) Sections through the malleus. In ETA/7/ chimeras, ETA/ cells (blue)
contribute to all of the malleus (m), including the body (b) and manubrium (mb), as well as the incus (i) (A). In ETA/7/ chimeras, ETA/ cells are
only found in the incus and in the perichondral mesenchyme at the articulation of the malleus and incus, but not in the perichondrium surrounding the malleus
(B). (C, D) Sections through the incus and stapes (s). Like the pattern observed in ETA/7/ chimeras (C), ETA/ cells in ETA/7/ chimeras are
observed in the base, crura, and head of the stapes as well as the incus, excluding the most ventral aspect of the long crus (arrowhead); this area is composed
solely of wild type (pink) cells (D). eam, external auditory meatus; otc, otic capsule; ttr, tubotympanic recess.
Fig. 7. Contribution of ETA/ and ETA/ cells to craniofacial structures of E18.5 chimeric embryos. As described in Fig. 3, the relative contribution of injected
cells is listed to the right of the embryo number ( to ). , structures composed of both injected and wild type cells; , structures composed of wild type
cells only; , structures that are absent. For comparison, the findings from ETA/ embryos are listed at the bottom; , structures that are present; , structures
that are malformed or absent. As observed in E13.5 embryos, both ventral and lateral structures in ETA/7/ chimeras are composed of both injected and wild
type cells. However, ventral structures in ETA/7/ chimeras are composed solely of wild type cells or are absent. Lateral structures are composed of both
ETA/ and wild type cells. ETA/7/ chimeras with extensive contribution of ETA/ cells have a cleft palate (*)
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cartilage, are composed solely of wild type cells, whereas
the incus, a maxillary arch derivative, is composed of both
wild type and mutant cells. In ETA/ 7 / chimeric
embryos containing a large percentage of ETA/ cells,
ETA/ cells do reach the ventral first mandibular arch, yet
final structures derived from this region do not form. This
indicates that crest-derived ectomesenchymal cells within
the mandibular arch have a cell-autonomous requirement
for ETA signaling in order to form bone and cartilage
structures. Such a requirement does not exist in the maxil-
lary portion of the first arch, suggesting that ETA signaling
is specifically required for patterning the mandibular arch.
The area within the mandibular arch requiring ETA sig-
naling for crest cell differentiation appears to coincide with
the location of epithelial ET-1 expression, observed primar-
ily in the caudoventral arch epithelium (Clouthier et al.,
1998; Maemura et al., 1996). Thus, proximity to ET-1 may
locally lead to ETA-dependent patterning of caudoventral
ectomesenchymal cells. However, it is also possible that
neural crest cells of different origins have different require-
ments for ETA signaling. Long-term fate maps of neural
crest cells in the chick have been used to generate similar
maps for the mouse (Kontges and Lumsden, 1996). Com-
parison of the localization of mandibular abnormalities in
ETA/7 / chimeras with these fate maps illustrate that
all affected structures are derived solely or partially from
midbrain crest cells (Fig. 10). This suggests that midbrain
crest cells may either be preprogrammed to have a specific
requirement for ETA signaling or become ET-1/ETA-depen-
dent as a result of their final location within the mandibular
arch. Since both preprogramming and local patterning by
arch-derived factors appear crucial for crest cell develop-
ment (Trainor and Krumlauf, 2002; Schneider and Helms,
2003), determining which of these aspects relies on ETA
signaling will have to await fate-mapping studies in ETA/
embryos.
ETA signaling and rostrolateral arch development
In ETA/ embryos, all three middle ear ossicles (mal-
leus, incus, and stapes) as well as the styloid process are
malformed or missing (Clouthier et al., 1998). In this study,
we found that the malleus of ETA/ 7 / chimeras was
composed solely of wild type cells, whereas the incus,
stapes, and styloid were each composed of a mixture of both
mutant and wild type cells. One interpretation of these
Fig. 9. Contribution of ETA/ and ETA/ cells to cardiovascular struc-
tures of E18.5 chimeric embryos. Arteries of the outflow tract examined are
listed along the top; the pharyngeal arch artery origin of each artery is listed
in parenthesis. As detailed in Fig. 3, the relative contribution of injected
cells is listed to the right of the embryo number ( to ). , struc-
tures composed of both injected and wild type cells; , structures com-
posed of wild type cells only. Observations from ETA/ embryos are
listed at the bottom; , structures that appear normal;, structures that are
malformed. While ETA/ and recipient wild type cells in ETA/7 /
chimeras are observed in the walls of all arteries, ETA/ cells in ETA/7
/ are only observed in the wall of the descending aorta. The walls of
arch artery-derived arteries are composed solely of wild type cells. Nota-
bly, ETA/ cells are excluded from the walls of the left and right common
carotid arteries, though these structures appear normal in ETA/ embryos.
A ventricular septal defect (†) is only observed in the ETA/7/
chimera with the highest contribution of ETA/ cells.
Fig. 8. Development of aortic arch elements in chimeric embryos. Sagittal (E10.0, A, B; and E18.5, E–H) and transverse (E13.5, C, D) sections from
ETA/7/ (A, C, E, G) and ETA/7/ (B, D, F, H) chimeric embryos. Twelve micrometer sections were stained for -galactosidase activity (blue)
and counterstained with eosin (pink). (A, B) Sections through the pharyngeal arch arteries of E10.0 embryos. While ETA/ cells (blue) in ETA/7/
chimeras are mixed around pharyngeal arch arteries 1, 2, and 3, ETA/ cells in ETA/7/ chimeras are absent from the arches, with the mesenchyme
surrounding the arch arteries instead composed only of wild type cells. Chimerism elsewhere in these embryos was roughly equal. (C, D) Sections through
the aortic arch of E13.5 embryos. In ETA/7/ chimeras, ETA/ cells (blue) are found in the walls of the pulmonary trunk (pt) and the aortic arch (aoa)
[proximal to the entrance of the ductus arteriosus (*)] at the junction of the left subclavian artery (C). In ETA/7/ chimeras, wild type cells (pink) are
not observed in the wall of the ductus arteriosus (arrowheads) and surrounding the aortic arch (D). ETA/ cells (blue) are still present in the wall of the
pulmonary trunk. (E, F) Sections through the left side of the aortic arch of E18.5 embryos. In ETA/7/ chimeras, ETA/ cells (blue; arrows and
arrowheads) are observed in the walls of the left common carotid artery (lcc; derived from left arch artery 3), aortic arch (ao; derived from left arch artery
4), and the ductus arteriosus (da; derived from left arch artery 6) (E). In ETA/7/ chimeras, ETA/ cells are absent from the walls of the left common
carotid artery, aorta and ductus arteriosus. Vessel walls are composed solely of wild type cells (pink) (F; arrows and arrowheads). (G, H) Sections through
the right side of the aortic arch. In ETA/7/ chimeras, ETA/ cells are observed in the walls of the right common carotid artery (rcc; derived from
right aortic arch 3) and the proximal right subclavian artery (rs; derived from right arch artery 4) (arrowheads) (G). In ETA/7/ chimeras, ETA/ cells
appear to be excluded from the walls of the subclavian and common carotid arteries (arrowheads) (H). e, esophagus; pal, pharyngeal arch 1; t, trachea; th,
thymus.
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results is that the maxillary portion of the first arch (incus)
and lateral region of the second arch (stapes and styloid)
require ETA signaling in a non-cell-autonomous manner,
indicating the presence of one or more ETA-dependent
paracrine mediators. However, it is also possible that the
formation of these elements does not require ETA signal-
ing, with their malformation in ETA/ embryos occur-
ring as a secondary result of the more severe changes in
the ventral arch. Tension exerted by neighboring tissues
or structures is believed to play a major role in facial
development (McGonnell et al., 1998). Loss of the mal-
leus, which disrupts normal articulations with the incus,
could in turn disrupt incus development in ETA/ em-
bryos. This would explain why the incus becomes de-
formed as the percentage of ETA/ cells in ETA/
7 / chimeras increases, even though the incus is still
composed of both wild type and mutant cells.
Abnormal bone development in the skull of ETA/7 /
chimeras
The most frequently observed structural abnormality
in the skull of ETA/7 / chimeras is the presence of
a strut-like bone that forms between the gonial and ptery-
goid bones. This strut is composed of both wild type and
ETA/ cells, suggesting a change in one or more down-
stream factors that normally specify development of mes-
enchymal cells in this region. This strut is never observed
in ETA/ embryos, possibly reflecting an absence of
precursor cells in mutant embryos due to mesenchymal
cell apoptosis occurring earlier in development
(Clouthier et al., 2000). Cell number dependency has
been hypothesized to occur during tympanic ring forma-
tion in Gsc/ 7 / chimeras (Rivera-Perez et al.,
1999). Mesenchymal bone struts are also observed in
Dlx2/ (Qiu et al., 1995, 1997) and Dlx5/ (Acampora
et al., 1999; Depew et al., 1999) embryos. Since the
expression of several Dlx genes requires ETA signaling
(Clouthier et al., 2000, Charite´ et al., 2001, and data not
shown), it is possible that strut formation in these differ-
ent mouse mutants results from the loss of a common
mesenchymal factor(s) that either induce or repress al-
ternative developmental pathways (possibly Dlx factors
themselves). Loss of Dlx5 and Dlx6 disrupts patterning of
the mandibular arch, resulting in an apparent homeotic
transformation of mandibular arch structures into maxil-
lary arch structures (Beverdam et al., 2002; Depew et al.,
2002). Since much of the mandibular arch-derived bone
in ETA/ mutant embryos is absent or severely de-
formed, it is difficult to determine whether a similar
homeotic transformation is present. Strategies that pro-
duce a more restricted loss of ETA receptor function will
be required to fully understand the role(s) of ETA signal-
ing in patterning the mandibular arch.
Cell-autonomous action of ETA during aortic arch
development
We previously demonstrated that the development of
arch 4 and 6 derivatives is disrupted in ETA/ embryos
(Clouthier et al., 1998; Yanagisawa et al., 1998b). In this
study, we found that ETA/ cells are excluded from caudal
arches 3, 4, and 6 in ETA/ 7 / chimeras, resulting in
the walls of arch arteries 3, 4, and 6 derivatives being
composed almost entirely of wild type cells. As described
above for cephalic neural crest development, these findings
suggest that ETA signaling is required in a cell-autonomous
manner for some aspect of cardiac neural crest develop-
ment, regardless of the arch artery segment with which they
are associated. It is interesting to note that outflow tract
defects were only observed in 14% of E18.5 ETA/7 /
chimeras examined, suggesting that the number of wild type
cardiac neural crest cells necessary for correct arch artery
remodeling may be quite small.
As described above for cephalic neural crest develop-
ment, the lack of ETA mutant cells in the arch artery walls
of mutant chimeras may result from a defect in cardiac crest
cell migration (Brault et al., 2001; Huang et al., 1998;
Waldo et al., 1999). Aberrant cardiac crest cell migration is
believed to be the cause of outflow tract defects in Pax3/
mice, in which the sixth arch-derived ductus arteriosus is
commonly affected (Conway et al., 1997). However, more
recent studies in which cardiac neural crest cells in Pax3/
embryos have been fate mapped suggest that Pax3, though
not essential for migration, is required for more subtle
aspects of crest cell development, possibly including the
final targeting of crest cells to the outflow tract (Epstein et
al., 2000). We previously demonstrated that expression of
CRABP1, a cardiac neural crest marker, was not grossly
altered in ETA/ embryos, suggesting that cardiac neural
crest cell migration is unaffected in ETA/ embryos
(Yanagisawa et al., 1998b). However, as observed in Pax3
mutant embryos, it is possible that loss of ETA signaling
affects the eventual targeting or survival of cardiac crest
cells, rather than their migration away from the neural tube.
Determining whether crest cell migration is affected in
ETA/ embryos will require extensive cardiac neural crest
fate mapping as well as determining the timing of ETA
receptor function.
Marked phenotypic similarities between ETA/ em-
bryos and mouse models of DiGeorge syndrome (Jerome
and Papaioannou, 2001; Lindsay et al, 2001; Merscher et
al., 2001; Kochilas et al., 2002; Vitelli et al., 2002) suggest
that ETA signaling may function within the same genetic
pathway involving Tbx1 and other gene(s) within the Di-
George-syntenic region. Further analyses of the role of
endothelin-mediated paracrine signaling in craniofacial and
cardiovascular development may lead to a better under-
standing of the molecular pathogenesis of DiGeorge syn-
drome.
517D.E. Clouthier et al. / Developmental Biology 261 (2003) 506–519
Acknowledgments
We thank Richard R. Behringer for critically reading this
manuscript and helpful discussions. We would also like to
thank Shelley Dixon, Sahar Seyedkalal, Shanna D. Maika,
and Elizabeth Loomis for technical help. M.Y. is an Inves-
tigator of the Howard Hughes Medical Institute. D.E.C. was
a fellow in the Division of Molecular Cardiology and was
supported by NIH Training Grant HL07360. This work was
supported in part by research grants from the Perot Family
Foundation and W.M. Keck Foundation.
References
Acampora, D., Merlo, G.R., Paleari, L., Zerega, B., Postiglione, M.P.,
Mantero, S., Bober, E., Barbieri, O., Simeone, A., Levi, G., 1999.
Craniofacial, vestibular and bone defects in mice lacking the Distal-
less-related gene Dlx5. Development 126, 3795–3809.
Baker, C.V.H., Bonner-Fraser, M., Le Douarin, N.M., Teillet, M.-A., 1997.
Early- and late-migrating neural crest cell populations have equivalent
developmental potential in vivo. Development 124, 3077–3087.
Beverdam, A., Merlo, G.R., Paleari, L., Mantero, S., Genova, F., Barbieri,
O., Janvier, P., Levi, G., 2002. Jaw transformation with gain or sym-
metry after Dlx5/Dlx 6 inactivation: mirror of the past. Genesis 34,
221–227.
Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D.H., McMahon,
A.P., Sommer, L., Roussadia, O., Kemler, R., 2001. Inactivation of the
-catenin gene by Wnt1-Cre-mediated deletion results in dramatic
brain malformation and failure of craniofacial development. Develop-
ment 128, 1253–1264.
Chai, Y., Jiang, X., Ito, Y., Bringas, P., Han, J., Rositch, D.H., Soriano, P.,
McMahon, A.P., Sucov, H.M., 2000. Fate of the mammalian cranial
neural crest during tooth and mandibular morphogenesis. Development
127, 1671–1679.
Charite´, J., McFadden, D.G., Merlo, G.R., Levi, G., Clouthier, D.E.,
Yanagisawa, M., Richardson, J.A., Olson, E.N., 2001. Role of Dlx6 in
regulation of an endothelin-1-dependent, dHAND branchial arch en-
hancer. Genes Dev. 15, 3039–3049.
Chen, Z.-F., Behringer, R.R., 1995. twist is required in head mesenchyme
for cranial neural tube morphogenesis. Genes Dev. 9, 686–699.
Clouthier, D.E., Hosoda, K., Richardson, J.A., Williams, S.C., Yanagi-
sawa, H., Kuwaki, T., Kumada, M., Hammer, R.E., Yanagisawa, M.,
1998. Cranial and cardiac neural crest defects in endothelin-A receptor-
deficient mice. Development 125, 813–824.
Fig. 10. Schematic representation of the cell-autonomous requirement of ETA signaling during pharyngeal arch development. The left side of the figure
illustrates that cephalic neural crest cells arising from the midbrain and hindbrain (color coded, matching the original color scheme used by Kontges and
Lumsden, 1996) and populating pharyngeal arches one and two (enlarged in box) give rise to most craniofacial structures (Kontges and Lumsden, 1996). Arch
areas that are dotted represent populations of crest-derived ectomesenchymal cells believed to have a cell-autonomous requirement for ETA receptor signaling.
In mutant chimeras, skull structures arising from these populations (stipled on right side of figure) are either composed solely of wild type cells or are missing.
Notably, structures that are composed of neural crest cells originating in the posterior midbrain appear to be most severely affected. al, alisphenoid bone; g,
gonial bone; i, incus; lh, lessor horns of the hyoid bone; m, malleus; ma, mandible; mc, Meckel’s cartilage; s, stapes; sq, squamosal bone; st, styloid; sth,
stylohyoid ligament; t, tympanic ring.
518 D.E. Clouthier et al. / Developmental Biology 261 (2003) 506–519
Clouthier, D.E., Williams, S.C., Yanagisawa, H., Wieduwilt, M., Richard-
son, J.A., Yanagisawa, M., 2000. Signaling pathways crucial for
craniofacial development revealed by endothelin-A receptor-deficient
mice. Dev. Biol. 217, 10–24.
Conway, S.J., Henderson, D.J., Copp, A.J., 1997. Pax3 is required for
cardiac neural crest migration in the mouse: evidence from the splotch
(Sp2H) mutant. Development 124, 505–514.
Creazzo, T.L., Godt, R.E., Leatherbury, L., Conway, S.J., Kirby, M.L.,
1998. Role of cardiac neural crest cells in cardiovascular development.
Annu. Rev. Physiol. 60, 267–286.
Depew, M.J., Liu, J.K., Long, J.E., Presley, R., Meneses, J.J., Pedersen,
R.A., Rubenstein, J.L.R., 1999. Dlx5 regulates regional development of
the branchial arches and sensory capsules. Development 126, 3831–
3846.
Depew, M.J., Lufkin, T., Rubenstein, J.L.R., 2002. Specification of jaw
subdivisions by Dlx genes. Science 298, 381–385.
Epstein, J.A., Li, J., Land, D., Chen, F., Brown, C.B., Jin, F., Lu, M.M.,
Thomas, M., Liu, E., Wessels, A., Lo, C.W., 2000. Migration of cardiac
neural crest cells in Splotch embryos. Development 127, 1869–1878.
Friedrich, G., Soriano, P., 1991. Promoter traps in embryonic stem cells: a
genetic screen to identify and mutate developmental genes in mice.
Genes Dev. 5, 1513–1525.
Huang, G.Y., Wessels, A., Smith, B.R., Linask, K.K., Ewart, J.L., Lo,
C.W., 1998. Alteration of connexin 43 gap junction gene dosage
impairs conotruncal heart development. Dev. Biol. 198, 32–44.
Jerome, L.A., Papaioannou, V.E., 2001. DiGeorge syndrome phenotype in
mice mutant for the T-box gene, Tbx1. Nat. Genet. 27, 286–291.
Kirby, M.L., Gale, T.F., Stewart, D.E., 1983. Neural crest cells contribute
to aorticopulmonary septation. Science 220, 1059–1061.
Kirby, M.L., Stewart, D.E., 1983. Neural crest origin of cardiac ganglion
cells in the chick embryo: identification and extirpation. Dev. Biol. 97,
433–443.
Kirby, M.L., Turnage, K.L., Hays, B.M., 1985. Characterization of
conotruncal malformations following ablation of “cardiac” neural crest.
Anat. Rec. 213, 87–93.
Kochilas, L., Merscher-Gomez, S., Lu, M.M., Potluri, V., Liao, J., Kucher-
lapati, R., Morrow, B., Epstein, J.A., 2002. The role of neural crest
during cardiac development in a mouse model of DiGeorge syndrome.
Dev. Biol. 251, 157–166.
Kontges, G., Lumsden, A., 1996. Rhombencephalic neural crest segmen-
tation is preserved throughout craniofacial ontogeny. Development
122, 3229–3242.
Kurihara, Y., Kurihara, H., Suzuki, H., Kodama, T., Maemura, K., Nagai,
R., Oda, H., Kuwaki, T., Cao, W.-H., Kamada, N., et al., 1994.
Elevated blood pressure and craniofacial abnormalities in mice defi-
cient in endothelin-1. Nature 368, 703–710.
Le Douarin, N.M., Ziller, C., Couly, G.F., 1993. Patterning of neural crest
derivatives in the avian embryo: in vivo and in vitro studies. Dev. Biol.
159, 24–49.
Le Lievre, C.S., Le Douarin, N.M., 1975. Mesenchymal derivatives of the
neural crest: analysis of chimaeric quail and chick embryos. J. Em-
bryol. Exp. Morphol. 34, 125–154.
Lindsay, E.A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T.,
Jurecic, V., Ogunrinu, G., Sutherland, H.F., Scambler, P.J., Bradley,
A., Baldini, A., 2001. Tbxl haploinsufficiency in the DiGeorge syn-
drome region causes aortic arch defects in mice. Nature 410, 97–101.
Lumsden, A., Sprawson, N., Graham, A., 1991. Segmental origin and
migration of neural crest cells in the hindbrain region of the chick
embryo. Development 113, 1281–1291.
Maemura, K., Kurihara, H., Kurihara, Y., Oda, H., Ishikawa, T., Copeland,
N.G., Gilbert, D.J., Jenkins, N.A., Yazaki, Y., 1996. Sequence analysis,
chromosomal location, and developmental expression of the mouse
preproendothelin-1 gene. Genomics 31, 177–184.
McGonnell, I.M., Clarke, J.D.W., Tickle, C., 1998. Fate map of the de-
veloping chick face: analysis of expansion of facial primordia and
establishment of the primary palate. Dev. Dyn. 212, 102–118.
Merscher, S., Funke, B., Epstein, J.A., et al., 2001. TBX1 is responsible for
cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell
104, 619–629.
Miller, C.T., Schilling, T.F., Lee, K.-H., Parker, J., Kimmel, C.B., 2000.
sucker encodes a zebrafish Endothelin-1 required for ventral pharyn-
geal arch development. Development 127, 3815–3838.
Noden, D.M., 1983. The role of the neural crest in patterning of avian
cranial skeletal, connective, and muscle tissues. Dev. Biol. 96, 144–
165.
Qiu, M., Bulfone, A., Ghattas, I., Meneses, J.J., Christensen, L., Sharpe,
P.T., Presley, R., Pedersen, R.A., Rubenstein, J.L.R., 1997. Role of the
Dlx homeobox genes in proximodistal patterning of the branchial
arches: Mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogen-
esis of proximal skeletal and soft tissue structures derived from the first
and second arches. Dev. Biol. 185, 165–184.
Qiu, M., Bulfone, A., Martinez, S., Meneses, J.J., Shimamura, K., Ped-
ersen, R.A., Rubenstein, J.L.R., 1995. Null mutation of Dlx-2 results in
abnormal morphogenesis of proximal first and second branchial arch
derivatives and abnormal differentiation in the forebrain. Genes Dev. 9,
2523–2538.
Rivera-Perez, J.A., Wakamiya, M., Behringer, R.R., 1999. Goosecoid acts
cell autonomously in mesenchyme-derived tissues during craniofacial
development. Development 126, 3811–3821.
Robertson, E.J., 1987. Embryo-derived stem cell lines, in: Robertson, E.J.
(Ed.), Teratocarcinomas and Embryonic Stem Cells: A Practical Ap-
proach, IRL Press Limited, Oxford, pp. 71–112.
Rossant, J., Spence, A., 1998. Chimeras and mosaics in mouse mutant
analysis. Trends Genet. 14, 358–363.
Schneider, R.A., Helms, J.A., 2003. The cellular and molecular origins of
beak morphology. Science 299, 565–568.
Serbedzija, G.N., Bronner-Fraser, M., Fraser, S.E., 1992. Vital dye analysis
of cranial neural crest cell migration in the mouse embryo. Develop-
ment 116, 297–307.
Trainor, P., Krumlauf, R., 2000. Plasticity in mouse neural crest cells
reveals a new patterning role for cranial mesoderm. Nat. Cell Biol. 2,
96–102.
Tran, C.M., Sucov, H.M., 1998. The RXR gene functions in a non-cell-
autonomous manner during mouse cardiac morphogenesis. Develop-
ment 125, 1951–1956.
Tucker, S.A., Yamada, G., Grigoriou, M., Pachnis, V., Sharpe, P.T., 1999.
Fgf-8 determines rostral-caudal polarity in the first branchial arch.
Development 126, 51–61.
Vitelli, F., Morishima, M., Taddei, I., Lindsay, E.A., Baldini, A., 2002.
Tbx1 mutation causes multiple cardiovascular defects and disrupts
neural crest and cranial nerve migratory pathways. Hum. Mol. Genet.
11, 915–922.
Waldo, K.L., Lo, C.W., Kirby, M.L., 1999. Connexin 43 expression re-
flects neural crest patterns during cardiovascular development. Dev.
Biol. 208, 307–323.
Xu, X., Li, W.E.I., Huang, G.Y., Meyer, R., Chen, T., Luo, Y., Thomas,
M.P., Radice, G.L, Lo, C.W., 2001. Modulation of mouse neural crest
cell motility by N-cadherin and connexin 43 gap junctions. J. Cell Biol.
154, 217–22.
Yanagisawa, H., Yanagisawa, M., Kapur, R.P., Richardson, J.A., Williams,
S.C., Clouthier, D.E., de Wit, D., Emoto, N., Hammer, R.E., 1998a.
Dual genetic pathways of endothelin-mediated intercellular signaling
revealed by targeted disruption of endothelin converting enzyme-1
gene. Development 125, 825–836.
Yanagisawa, H., Hammer, R.E., Richardson, J.A., Williams, S.C.,
Clouthier, D.E., Yanagisawa, M., 1998b. Role of endothelin-1/endo-
thelin-A receptor-mediated signaling pathway in the aortic arch pat-
terning in mice. J. Clin. Invest. 102, 22–33.
Zambrowicz, B.P., Zimmermann, J.W., Harendza, C.J., Simpson, E.M.,
Page, D.C., Brinster, R.L., Palmiter, R.D., 1994. Expression of a mouse
Zfy-1/lacZ transgene in the somatic cells of the embryonic gonad and
germ cells of the adult testis. Development 120, 1549–1559.
519D.E. Clouthier et al. / Developmental Biology 261 (2003) 506–519
